1. Home
  2. FIGS vs KARD Comparison

FIGS vs KARD Comparison

Compare FIGS & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FIGS Inc.

FIGS

FIGS Inc.

HOLD

Current Price

$14.77

Market Cap

2.1B

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$20.36

Market Cap

1.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FIGS
KARD
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
FIGS
KARD
Price
$14.77
$20.36
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$15.93
N/A
AVG Volume (30 Days)
3.5M
212.0K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
850.00
N/A
EPS
0.18
N/A
Revenue
$419,591,000.00
N/A
Revenue This Year
$14.09
N/A
Revenue Next Year
$7.72
N/A
P/E Ratio
$82.44
N/A
Revenue Growth
59.47
N/A
52 Week Low
$6.50
$19.58
52 Week High
$17.48
$27.00

Technical Indicators

Market Signals
Indicator
FIGS
KARD
Relative Strength Index (RSI) 79.30 43.46
Support Level $11.15 $19.71
Resistance Level $16.01 $24.82
Average True Range (ATR) 0.78 1.31
MACD 0.49 0.13
Stochastic Oscillator 75.53 19.57

Price Performance

Historical Comparison
FIGS
KARD

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: